Aug 20 |
Liquidia’s YUTREPIA inhalation powder gains tentative FDA approval
|
Aug 19 |
Top Midday Decliners
|
Aug 19 |
Why Nikola Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
|
Aug 19 |
Why Liquidia Stock Just Reversed Its Seven-Day Sprint And Crashed 38%
|
Aug 19 |
Biggest stock movers today: ZIM, AMD, FUBO, EBS, and more
|
Aug 19 |
Liquidia down 34% after FDA decision delays potential launch of Yutrepia
|
Aug 19 |
Estee Lauder, Liquidia, B. Riley fall premarket; AMD rises
|
Aug 19 |
3 US Growth Companies With High Insider Ownership
|
Aug 19 |
U.S. FDA Grants Tentative Approval of YUTREPIA™ (treprostinil) Inhalation Powder for Patients with Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)
|
Aug 16 |
Liquidia draws bullish view at Raymond James on Yutrepia potential
|